1951–1964

Diffusion-Controlled Release in Solids

Diffusion emerges as the central design principle for controlled release across disciplines. Researchers formulate diffusion-dominated kinetics to explain the sustained action of solid-dose systems and implantable carriers. Parallel work investigates diffusion processes in materials to optimize device performance. This cross-disciplinary framework guides the early development of solid matrices and polymer-based carriers with predictable release.

Period 1951-1964: Researchers used spectroscopy and semiconductor diffusion to study solid defects and release kinetics[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17]. Seminal matrix models and silicone carriers established quantitative diffusion kinetics for sustained drug delivery[18][19][20].

1965–1994

Polymeric Carriers and Biodegradable Delivery

Polymer-based carriers and bioadhesive platforms drove sustained-release strategies through biodegradable matrices and mucosal adhesion. Release kinetics relied on diffusion, swelling, and pH-responsive behavior alongside a power-law framework for transport mechanisms. Self-assembled block copolymer micelles and PLGA-based microspheres enabled long-acting injectable and hydrophobic drug therapies. Biodegradable hydrogels and liposome designs further advanced implantable and thermally triggered localized delivery systems.

Period 1965-1994: Biocompatible matrices, predictive kinetic models, PLGA microspheres, and bioadhesive platforms drove sustained oral and injectable delivery[1][2][3][4][5][6][7][8][9][10][11][12][13][14]. Power-law frameworks, block copolymer micelles, hydrogels, and thermally triggered liposomes established foundational nanocarrier designs[15][16][17][18][19].

1995–2009

Stimuli-Responsive Nanocarriers and Smart Delivery Systems

Researchers developed multifunctional polymeric nanocarriers, block copolymer micelles, and hydrogels for targeted and sustained drug release. Environment-responsive strategies utilized thermo-, pH-, and redox-sensitive materials alongside light-activated and magnetically triggered systems. Mechanistic release kinetics modeling and surface engineering supported the design of diverse parenteral, oral, and mucosal platforms. Biocompatibility and safety assessments guided the formulation of advanced long-acting and implantable delivery technologies.

Period 1995-2001: Polymeric nanocarriers, hydrogels, and stimuli-responsive matrices governed controlled drug delivery, integrating diffusion-swelling models and safety assessments[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17]. Landmark polymer frameworks, micelles, stimuli-responsive hydrogels, and mesoporous silica shaped modern smart delivery[18][19][20][21]. Period 2002-2009: Carrier materials diversified into polymers, lipids, and silica alongside stimuli-responsive mechanisms, kinetic modeling, and surface engineering for on-demand delivery[22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39]. Foundational reviews and studies on hydrogels, smart polymers, mesoporous silica, and nanosuspensions shaped subsequent targeted and responsive nanocarrier platforms[40][41][42][43][44].

2010–2024

Stimuli-Responsive and Gated Drug Delivery

Researchers engineered programmable payload deployment using gateable nanostructures, stimuli-responsive carriers, and biodegradable polymers. Porous silica, hydrogels, and lipid-based systems enabled on-demand release via pH, redox, and thermal cues. Remote actuation and microneedle platforms advanced targeted therapy and transdermal delivery. The field increasingly emphasized translation, bridging fundamental design principles with clinical commercialization.

Period 2010-2016: Researchers engineered gated mesoporous silica and polymer carriers for on-demand drug release using pH, enzyme, and remote triggers[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16]. These foundational studies on biodegradable polymers, hydrogels, multi-stimuli carriers, and 2D materials established design principles for smart, clinically relevant platforms[17][18][19][20]. Period 2017-2024: Polymeric nanogels, microneedle platforms, lipid carriers, and hydrogels achieved on-demand, targeted release via diverse environmental cues[21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36]. Foundational nanoprecipitation, lipid formulations, metal-organic frameworks, and precision nanoparticle designs shaped clinical translation and commercialization[32][37][38][39].